Literature DB >> 25882805

Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit.

Carlos A Jiménez-Ruiz1, Stefan Andreas2, Keir E Lewis3, Philip Tonnesen4, C P van Schayck5, Peter Hajek6, Serena Tonstad7, Bertrand Dautzenberg8, Monica Fletcher9, Sarah Masefield10, Pippa Powell10, Thomas Hering11, Stefano Nardini12, Thomy Tonia13, Christina Gratziou14.   

Abstract

Chronic obstructive pulmonary disease (COPD), lung cancer, asthma and pulmonary tuberculosis are common pulmonary diseases that are caused or worsened by tobacco smoking. Growing observational evidence suggests that symptoms and prognosis of these conditions improve upon smoking cessation. Despite increasing numbers of (small) randomised controlled trials suggesting intensive smoking cessation treatments work in people with pulmonary diseases many patients are not given specific advice on the benefits or referred for intensive cessation treatments and, therefore, continue smoking.This is a qualitative review regarding smoking cessation in patients with COPD and other pulmonary disorders, written by a group of European Respiratory Society experts. We describe the epidemiological links between smoking and pulmonary disorders, the evidence for benefits of stopping smoking, how best to assess tobacco dependence and what interventions currently work best to help pulmonary patients quit. Finally, we describe characteristics and management of any "hardcore" smoker who finds it difficult to quit with standard approaches.
Copyright ©ERS 2015.

Entities:  

Mesh:

Year:  2015        PMID: 25882805     DOI: 10.1183/09031936.00092614

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  39 in total

Review 1.  Eosinophilic and Noneosinophilic Asthma.

Authors:  Tara F Carr; Amir A Zeki; Monica Kraft
Journal:  Am J Respir Crit Care Med       Date:  2018-01-01       Impact factor: 21.405

2.  Treatment of tobacco dependence in UK hospitals: an observational study.

Authors:  John Hutchinson; Zaheer Mangera; Laura Searle; Anna Lewis; Sanjay Agrawal
Journal:  Clin Med (Lond)       Date:  2018-02       Impact factor: 2.659

3.  Smoking cessation by combined medication and counselling: a feasibility study in lung cancer patients.

Authors:  Christian Reinhardt; Markus Harden; Christoph Herrmann-Lingen; Achim Rittmeyer; Stefan Andreas
Journal:  BMC Pulm Med       Date:  2022-06-27       Impact factor: 3.320

4.  Symptomatic smokers without COPD have physiological changes heralding the development of COPD.

Authors:  Erica Bazzan; Umberto Semenzato; Graziella Turato; Davide Biondini; Pablo Cubero; Marta Marin-Oto; Marta Forner; Mariaenrica Tinè; Alvise Casara; Simonetta Baraldo; Paolo Spagnolo; Jose M Marin; Marina Saetta; Manuel G Cosio
Journal:  ERJ Open Res       Date:  2022-06-27

5.  Documentation of smoking in scheduled asthma contacts in primary health care: a 12-year follow-up study.

Authors:  Jaana Takala; Iida Vähätalo; Leena E Tuomisto; Onni Niemelä; Pinja Ilmarinen; Hannu Kankaanranta
Journal:  NPJ Prim Care Respir Med       Date:  2022-10-21       Impact factor: 3.289

Review 6.  Quality of smoking cessation advice in guidelines of tobacco-related diseases: An updated systematic review.

Authors:  Winifred Ekezie; Rachael L Murray; Sanjay Agrawal; Ilze Bogdanovica; John Britton; Jo Leonardi-Bee
Journal:  Clin Med (Lond)       Date:  2020-11       Impact factor: 2.659

7.  It's never too late: Smoking cessation after stereotactic body radiation therapy for non-small cell lung carcinoma improves overall survival.

Authors:  Michael C Roach; Sana Rehman; Todd A DeWees; Christopher D Abraham; Jeffrey D Bradley; Cliff G Robinson
Journal:  Pract Radiat Oncol       Date:  2015-09-18

8.  Smoking cessation and outcome after ischemic stroke or TIA.

Authors:  Katherine A Epstein; Catherine M Viscoli; J David Spence; Lawrence H Young; Silvio E Inzucchi; Mark Gorman; Brett Gerstenhaber; Peter D Guarino; Anand Dixit; Karen L Furie; Walter N Kernan
Journal:  Neurology       Date:  2017-09-08       Impact factor: 9.910

9.  [Choosing wisely together with the patient].

Authors:  U R Fölsch; G Hasenfuß
Journal:  Internist (Berl)       Date:  2016-06       Impact factor: 0.743

Review 10.  Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance.

Authors:  Lloyd Tanner; Andrew Bruce Single
Journal:  J Innate Immun       Date:  2019-09-17       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.